Rebecca E Krueger

5PUBLICATIONS

47CO-AUTHORS

Medical infection agents (incl. prions)Biomolecular modelling and designPharmacology and pharmaceutical sciences not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 22, 2026

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

|Nov 20, 2024

Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.

Stephen R Welch, Jessica R Spengler, Jonna B Westover

|Feb 08, 2024

Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.

Robert M Cox, Josef D Wolf, Nicole A Lieberman

|Oct 18, 2023

Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 Mpro Inhibitors.

Leon Jacobs, Aletta van der Westhuyzen, Nicole Pribut

|Aug 07, 2023

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.

Robert M Cox, Carolin M Lieber, Josef D Wolf

Pageof 1

Frequent Collaborators

Zachary M Sticher

Meghan K Andrews

Josef D Wolf

Richard K Plemper

Robert M Cox

Nicole A P Lieberman

George R Painter

Alexander L Greninger

2 joint publications

Jeong-Joong Yoon

1 joint publications

Amalia A Cruz

Frequent Collaborators

Zachary M Sticher

Meghan K Andrews

Josef D Wolf

Richard K Plemper